Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)

NCT06080256 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Intracranial Atherosclerosis
Atherosclerotic Plaque
Stenosis

Interventions

DRUG: Alirocumab
DRUG: Atorvastatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University